{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:56:13Z","timestamp":1777992973879,"version":"3.51.4"},"reference-count":102,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T00:00:00Z","timestamp":1668297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.heliyon.2022.e11744","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T02:51:12Z","timestamp":1668739872000},"page":"e11744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Profiles of host immune impairment in Plasmodium and SARS-CoV-2 infections"],"prefix":"10.1016","volume":"8","author":[{"given":"Rini","family":"Chaturvedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mradul","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8181-3999","authenticated-orcid":false,"given":"Sanjeev","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anmol","family":"Chandele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2022.e11744_bib1","series-title":"WHO Coronavirus Disease (COVID-19) Dashboard","year":"2021"},{"key":"10.1016\/j.heliyon.2022.e11744_bib2","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cmi.2020.05.019","article-title":"Review of trials currently testing treatment and prevention of COVID-19","volume":"26","author":"Fragkou","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.heliyon.2022.e11744_bib4","article-title":"The impact of COVID-19 pandemic on malaria elimination","volume":"11","author":"Zawawi","year":"2020","journal-title":"Parasite Epidemiol. Control"},{"key":"10.1016\/j.heliyon.2022.e11744_bib8","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200288","article-title":"Epidemiological profiles and associated risk factors of SARS-CoV-2 positive patients based on a high-throughput testing facility in India","volume":"11","author":"Malhotra","year":"2021","journal-title":"Open Biol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1586\/eri.13.45","article-title":"The silent threat: asymptomatic parasitemia and malaria transmission","volume":"11","author":"Lindblade","year":"2014","journal-title":"Expert Rev. Anti-infect. Ther."},{"key":"10.1016\/j.heliyon.2022.e11744_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pt.2015.11.015","article-title":"Malaria parasites in the asymptomatic: looking for the hay in the haystack","volume":"32","author":"Galatas","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib11","series-title":"The Impact of Covid-19 On HIV, TB and Malaria Services and Systems for Health: A Snapshot From 502 Health Facilities Across Africa and Asia","year":"2021"},{"key":"10.1016\/j.heliyon.2022.e11744_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1756-3305-6-18","article-title":"Effect of malaria on HIV\/AIDS transmission and progression","volume":"6","author":"Alemu","year":"2013","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.heliyon.2022.e11744_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2015.11.006","article-title":"Impacts of neglected tropical disease on incidence and progression of HIV\/AIDS, tuberculosis, and malaria: scientific links","author":"Simon","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2022.e11744_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2022.03.028","article-title":"Impact of COVID-19 and malaria coinfection on clinical outcomes: a retrospective cohort study","author":"Hussein","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.heliyon.2022.e11744_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009766","article-title":"Prevalence and characteristics of malaria among COVID-19 individuals: a systematic review, meta-analysis, and analysis of case reports","volume":"15","author":"Wilairatana","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2022.e11744_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/trstmh\/traa108","article-title":"Overlaying COVID-19 mitigation plans on malaria control infrastructures","volume":"115","author":"Rahi","year":"2021","journal-title":"Trans. R. Soc. Trop. Med. Hygiene"},{"key":"10.1016\/j.heliyon.2022.e11744_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4269\/ajtmh.20-0394","article-title":"COVID-19 mitigation steps provide a blueprint for malaria control and elimination","volume":"103","author":"Rahi","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2022.e11744_bib18","first-page":"1","article-title":"Organ-specific manifestations of COVID-19 infection","author":"Gavriatopoulou","year":"2020","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2020.07.014","article-title":"COVID-19 and comorbidities: deleterious impact on infected patients","author":"Ejaz","year":"2020","journal-title":"J.\u00a0Infect. Public Health"},{"key":"10.1016\/j.heliyon.2022.e11744_bib20","series-title":"Acute Lung Injury and Acute Respiratory Distress Syndrome in Malaria","author":"Mohan","year":"2008"},{"key":"10.1016\/j.heliyon.2022.e11744_bib21","series-title":"World Malaria Report","year":"2019"},{"key":"10.1016\/j.heliyon.2022.e11744_bib22","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2022.e11744_bib23","series-title":"Coronavirus Disease 2019 Case Surveillance \u2013 United States, January 22-May 30, 2020, morbidity and mortality weekly report (MMWR)","first-page":"759","volume":"69","author":"Stokes","year":"2020"},{"key":"10.1016\/j.heliyon.2022.e11744_bib24","doi-asserted-by":"crossref","first-page":"n879","DOI":"10.1136\/bmj.n879","article-title":"Covid-19: Brazil\u2019s spiralling crisis is increasingly affecting young people","volume":"373","author":"Taylor","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2022.e11744_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41390-020-0881-y","article-title":"COVID-19 in children and altered inflammatory responses","author":"Molloy","year":"2020","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.heliyon.2022.e11744_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-4642(20)30135-8","article-title":"The immune system of children: the key to understanding SARS-CoV-2 susceptibility?","author":"Carsetti","year":"2020","journal-title":"Lancet Child Adolescent Health"},{"key":"10.1016\/j.heliyon.2022.e11744_bib27","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI85113","article-title":"Human regulatory B cells in health and disease: therapeutic potential","volume":"127","author":"Mauri","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.heliyon.2022.e11744_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cytogfr.2020.05.002","article-title":"COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons","volume":"53","author":"Nile","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.heliyon.2022.e11744_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMoa072727","article-title":"Severe anemia in Malawian children","volume":"358","author":"Callis","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib30","series-title":"Severe Malaria, Tropical Medicine & International Health: TM & IH","first-page":"7","volume":"19","year":"2014"},{"key":"10.1016\/j.heliyon.2022.e11744_bib31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-3156.2007.01881.x","article-title":"A\u00a0quantitative ultrastructural study of renal pathology in fatal Plasmodium falciparum malaria","volume":"12","author":"Nguansangiam","year":"2007","journal-title":"Trop. Med. Int. Health: TM & IH"},{"key":"10.1016\/j.heliyon.2022.e11744_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000453397","article-title":"Cellular innate immunity: an old game with new players","volume":"9","author":"Gasteiger","year":"2017","journal-title":"J.\u00a0Innate Immun."},{"key":"10.1016\/j.heliyon.2022.e11744_bib33","article-title":"Cytokines and their role in health and disease: a brief overview","volume":"4","author":"Roy","year":"2016","journal-title":"MOJ Immunol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1467538","article-title":"The regulation of inflammation by innate and adaptive lymphocytes","volume":"2018","author":"Cronkite","year":"2018","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.heliyon.2022.e11744_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.heliyon.2022.e11744_bib36","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib37","article-title":"The cytokine storm and COVID-19","author":"Hu","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2022.e11744_bib39","article-title":"Multiple enzyme release, inflammation storm and hypercoagulability are prominent indicators for disease progression in COVID-19: a multi-centered, correlation study with CT imaging score","author":"Wang","year":"2020","journal-title":"SSRN Electron. J."},{"key":"10.1016\/j.heliyon.2022.e11744_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-020-02571-x","article-title":"Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study","author":"Zhang","year":"2020","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib41","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3899\/jrheum.150613","article-title":"Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis receiving background methotrexate therapy: a 12-week, double-blind, randomized placebo-controlled study","volume":"43","author":"Tanaka","year":"2016","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib42","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3389\/fmicb.2019.01057","article-title":"The role of interleukin 6 during viral infections","volume":"10","author":"Velazquez-Salinas","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib43","unstructured":"Interleukin-6 Inhibitors, NIH COVID-19 Treatment Guidelines. (n.d.). https:\/\/www.covid19treatmentguidelines.nih.gov\/immunomodulators\/interleukin-6-inhibitors\/#:&#x223C;:text=Receptor%20Monoclonal%20Antibodies-TocilizumabCAR%20T%2Dcell)%20therapy (accessed April 25, 2021)."},{"key":"10.1016\/j.heliyon.2022.e11744_bib44","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012697","article-title":"The Sacco Baricitinib Study Group, Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients","volume":"12","author":"Stebbing","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib45","first-page":"5298","article-title":"Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050","volume":"184","author":"Fridman","year":"2010","journal-title":"J.I."},{"key":"10.1016\/j.heliyon.2022.e11744_bib46","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.heliyon.2022.e11744_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","author":"Han","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.heliyon.2022.e11744_bib49","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.4049\/jimmunol.165.3.1612","article-title":"Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression","volume":"165","author":"Benkhart","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139834","article-title":"Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease","author":"Zhao","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.heliyon.2022.e11744_bib51","first-page":"10","article-title":"A\u00a0potential role of interleukin-10 in COVID-19 pathogenesis","volume":"xx","author":"Lu","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/1471-2334-13-341","article-title":"Serum IL-10 as a marker of severe dengue infection","volume":"13","author":"Malavige","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.heliyon.2022.e11744_bib53","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib54","article-title":"Preventing mortality in COVID-19 patients: which cytokine to target in a raging storm?","author":"Lu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm.3424","article-title":"Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection","volume":"20","author":"Liehl","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib56","series-title":"Setting the Stage: the Initial Immune Response to Blood-Stage Parasites","author":"Buc\u015fan","year":"2020"},{"key":"10.1016\/j.heliyon.2022.e11744_bib57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2220\/biomedres.32.203","article-title":"Cytokine profile of murine malaria: stage-related production of inflammatory and anti-inflammatory cytokines","volume":"32","author":"Bakir","year":"2011","journal-title":"Biomed. Res."},{"key":"10.1016\/j.heliyon.2022.e11744_bib58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jare.2020.02.016","article-title":"Immune responses in liver and spleen against Plasmodium yoelii pre-erythrocytic stages in Swiss mice model","volume":"24","author":"Siddiqui","year":"2020","journal-title":"J.\u00a0Adv. Res."},{"key":"10.1016\/j.heliyon.2022.e11744_bib59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/21505594.2019.1708053","article-title":"Setting the stage: the initial immune response to blood-stage parasites","author":"Buc\u015fan","year":"2020","journal-title":"Virulence"},{"key":"10.1016\/j.heliyon.2022.e11744_bib60","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1128\/IAI.00211-09","article-title":"Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea","volume":"77","author":"Robinson","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.heliyon.2022.e11744_bib61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0002-9343(89)80688-6","article-title":"Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria","volume":"87","author":"Kern","year":"1989","journal-title":"Am. J. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib62","series-title":"Interleukin-6 as a Potential Biomarker of COVID-19 Progression","author":"Ulhaq","year":"2020"},{"key":"10.1016\/j.heliyon.2022.e11744_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00533-16","article-title":"Cytokine profiles in Malawian children presenting with uncomplicated malaria, severe malarial anemia, and cerebral malaria","volume":"24","author":"Mandala","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib64","doi-asserted-by":"crossref","DOI":"10.1179\/136485905X51508","article-title":"High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria","author":"Armah","year":"2005","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib65","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1086\/315078","article-title":"Cytokine expression in the brain in human cerebral malaria","volume":"180","author":"Brown","year":"1999","journal-title":"JID (J. Infect. Dis.)"},{"key":"10.1016\/j.heliyon.2022.e11744_bib66","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s12936-017-2148-6","article-title":"Both inflammatory and regulatory cytokine responses to malaria are blunted with increasing age in highly exposed children","volume":"16","author":"Farrington","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.heliyon.2022.e11744_bib67","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1183\/09031936.96.09091858","article-title":"Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema","volume":"9","author":"Schutte","year":"1996","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2022.e11744_bib68","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2022.e11744_bib69","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.bbagen.2016.04.003","article-title":"Tumor necrosis factor reduces Plasmodium falciparum growth and activates calcium signaling in human malaria parasites","volume":"1860","author":"Cruz","year":"2016","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.heliyon.2022.e11744_bib70","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.1128\/IAI.69.11.6651-6659.2001","article-title":"Critical role for tumor necrosis factor Alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis","volume":"69","author":"Gon\u00e7alves","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.heliyon.2022.e11744_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2016.00630","article-title":"Effects of interferons and viruses on metabolism","volume":"7","author":"Fritsch","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib72","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1159\/000495897","article-title":"Type i interferons: distinct biological activities and current applications for viral infection","volume":"51","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2022.e11744_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4864","article-title":"Pathogenic potential of interferon \u03b1\u03b2 in acute influenza infection","volume":"5","author":"Davidson","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2022.e11744_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2022.e11744_bib75","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2022.e11744_bib76","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib77","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","article-title":"A\u00a0single-cell atlas of the peripheral immune response in patients with severe COVID-19","volume":"26","author":"Wilk","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib78","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","article-title":"Heightened innate immune responses in the respiratory tract of COVID-19 patients","volume":"27","author":"Zhou","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.heliyon.2022.e11744_bib79","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201241","article-title":"Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling","volume":"217","author":"Israelow","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib80","article-title":"Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis","volume":"34","author":"Ramasamy","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.heliyon.2022.e11744_bib81","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1038\/s41467-021-27318-0","article-title":"Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2","volume":"12","author":"Hatton","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2022.e11744_bib82","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pt.2016.12.010","article-title":"Type I interferon in malaria: a balancing act","volume":"33","author":"Mooney","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib83","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.celrep.2014.03.018","article-title":"Interferon-mediated innate immune responses against malaria parasite liver stages","volume":"7","author":"Miller","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.heliyon.2022.e11744_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2020.594621","article-title":"Type I interferons and malaria: a double-edge sword against a complex parasitic disease","volume":"10","author":"He","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib85","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/eji.201343327","article-title":"Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA","volume":"43","author":"Palomo","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib86","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.celrep.2016.09.015","article-title":"Type I interferons regulate immune responses in humans with blood-stage Plasmodium falciparum infection","volume":"17","author":"Montes de Oca","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.heliyon.2022.e11744_bib87","doi-asserted-by":"crossref","first-page":"e6867","DOI":"10.1073\/pnas.1706915114","article-title":"Interferon-\u03b3 is a master checkpoint regulator of cytokine-induced differentiation","volume":"114","author":"Zha","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2022.e11744_bib88","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005118","article-title":"Interferon-\u03b3: the jekyll and hyde of malaria","volume":"11","author":"King","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2022.e11744_bib90","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1515\/bmc-2018-0007","article-title":"Interferon-gamma (IFN-\u03b3): exploring its implications in infectious diseases","volume":"9","author":"Kak","year":"2018","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.heliyon.2022.e11744_bib91","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2022.e11744_bib92","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM198906153202404","article-title":"Tumor necrosis factor and disease severity in children with falciparum malaria","author":"Grau","year":"1989","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib93","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.89.8.3200","article-title":"Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in plasmodium vivax Malaria","author":"Karunaweera","year":"1992","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2022.e11744_bib94","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.1995.53.532","article-title":"Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production","author":"Kremsner","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2022.e11744_bib95","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1086\/367960","article-title":"Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria","volume":"187","author":"Grau","year":"2003","journal-title":"JID (J. Infect. Dis.)"},{"key":"10.1016\/j.heliyon.2022.e11744_bib96","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1084\/jem.176.4.1183","article-title":"Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1","volume":"176","author":"Ockenhouse","year":"1992","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib97","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.vph.2006.11.005","article-title":"Endothelial injury in the initiation and progression of vascular disorders","volume":"46","author":"Tesfamariam","year":"2006","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib98","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4049\/jimmunol.159.2.912","article-title":"Cytokine-induced neutrophil-mediated injury of human endothelial cell","volume":"159","author":"Bratt","year":"1997","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib99","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6175964","article-title":"Pulmonary fibrosis in COVID-19 survivors: predictive factors and risk reduction strategies","author":"Ojo","year":"2020","journal-title":"Pulmonary Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib100","article-title":"Cytokine storm: the primary determinant for the pathophysiological evolution of COVID-19 deterioration","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib101","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2022.e11744_bib102","series-title":"Vascular Permeability Factor\/Vascular Endothelial Growth Factor and the Significance of Microvascular Hyperpermeability in Angiogenesis, Vascular Growth Factors and Angiogenesis","first-page":"237","author":"Dvorak","year":"1999"},{"key":"10.1016\/j.heliyon.2022.e11744_bib103","first-page":"10","article-title":"Clinical features and outcomes of four HIV patients with COVID-19 in Wuhan, China","author":"Ruan","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib104","series-title":"Current Topics in Malaria","article-title":"Multiple organ dysfunction during severe malaria: the role of the inflammatory response","author":"Souza","year":"2016"},{"key":"10.1016\/j.heliyon.2022.e11744_bib105","article-title":"Amplification of P. falciparum cytoadherence through induction of a pro-adhesive state in host endothelium","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2022.e11744_bib106","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fcimb.2014.00100","article-title":"Pathogenesis of cerebral malaria\u2014inflammation and cytoadherence","volume":"4","author":"Storm","year":"2014","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.heliyon.2022.e11744_bib107","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-2600(21)00218-6","article-title":"The COVID-19 puzzle: deciphering pathophysiology and\u00a0phenotypes of a new disease entity","volume":"9","author":"Osuchowski","year":"2021","journal-title":"Lancet Respir. Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022030328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022030328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T13:59:38Z","timestamp":1767103178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022030328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":102,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2405844022030328"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11744","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiles of host immune impairment in Plasmodium and SARS-CoV-2 infections","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e11744"}}